Kessler L, Koo C, Richter C, Tan X
Am J Cancer Res. 2024; 14(9):4597-4632.
PMID: 39417180
PMC: 11477841.
DOI: 10.62347/OKGQ4382.
Barbanente A, Papadia P, Di Cosola A, Pacifico C, Natile G, Hoeschele J
Int J Mol Sci. 2024; 25(13).
PMID: 39000496
PMC: 11242235.
DOI: 10.3390/ijms25137392.
Ziegler D, Cleve C, Ziegler S, Schirmer M, Fischer L, Bohnenberger H
Cancers (Basel). 2024; 16(11).
PMID: 38893074
PMC: 11171404.
DOI: 10.3390/cancers16111953.
Elbeltagy A, Mohamed G, Akeel M, Abdelaziz K, Elbakry K, Elsayed A
F1000Res. 2023; 11:504.
PMID: 37547786
PMC: 10403747.
DOI: 10.12688/f1000research.111293.1.
Vishwasrao H, Master A, Seo Y, Liu X, Pothayee N, Zhou Z
Chem Mater. 2023; 28(9):3024-3040.
PMID: 37405207
PMC: 10317193.
DOI: 10.1021/acs.chemmater.6b00197.
Nanotechnology Approaches for Prevention and Treatment of Chemotherapy-Induced Neurotoxicity, Neuropathy, and Cardiomyopathy in Breast and Ovarian Cancer Survivors.
Nevins S, McLoughlin C, Oliveros A, Stein J, Rashid M, Hou Y
Small. 2023; 20(41):e2300744.
PMID: 37058079
PMC: 10576016.
DOI: 10.1002/smll.202300744.
Revisiting the Anti-Cancer Toxicity of Clinically Approved Platinating Derivatives.
Forgie B, Prakash R, Telleria C
Int J Mol Sci. 2022; 23(23).
PMID: 36499737
PMC: 9793759.
DOI: 10.3390/ijms232315410.
Ameliorative impacts of polymeric and metallic nanoparticles on cisplatin-induced nephrotoxicity: a 2011-2022 review.
Davoudi M, Jadidi Y, Moayedi K, Farrokhi V, Afrisham R
J Nanobiotechnology. 2022; 20(1):504.
PMID: 36457031
PMC: 9714065.
DOI: 10.1186/s12951-022-01718-w.
Cisplatin adducts of DNA as precursors for nanostructured catalyst materials.
Englert K, Hendi R, Robbs P, Rees N, Robinson A, Tucker J
Nanoscale Adv. 2022; 2(10):4491-4497.
PMID: 36132916
PMC: 9417135.
DOI: 10.1039/d0na00528b.
Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity.
Domingo I, Latif A, Bhavsar A
Int J Mol Sci. 2022; 23(13).
PMID: 35806229
PMC: 9266867.
DOI: 10.3390/ijms23137227.
Current Developments of -Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment.
Tialiou A, Chin J, Keppler B, Reithofer M
Biomedicines. 2022; 10(6).
PMID: 35740438
PMC: 9219884.
DOI: 10.3390/biomedicines10061417.
Cytotoxicity of Alizarine versus Tetrabromocathecol Cyclometalated Pt(II) Theranostic Agents: A Combined Experimental and Computational Investigation.
Mazzone G, Scoditti S, Caligiuri R, Ricciardi L, Sicilia E, Lupo M
Inorg Chem. 2022; 61(18):7188-7200.
PMID: 35467854
PMC: 9092348.
DOI: 10.1021/acs.inorgchem.2c00842.
High loading of trimethylglycine promotes aqueous solubility of poorly water-soluble cisplatin.
Kadokawa R, Fujie T, Sharma G, Ishibashi K, Ninomiya K, Takahashi K
Sci Rep. 2021; 11(1):9770.
PMID: 33963207
PMC: 8105311.
DOI: 10.1038/s41598-021-89144-0.
The Biological Role of the Collagen Alpha-3 (VI) Chain and Its Cleaved C5 Domain Fragment Endotrophin in Cancer.
Wang J, Pan W
Onco Targets Ther. 2020; 13:5779-5793.
PMID: 32606789
PMC: 7319802.
DOI: 10.2147/OTT.S256654.
Increased CD4 T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients.
Bergman E, Hartana C, Johansson M, Linton L, Berglund S, Hyllienmark M
Clin Epigenetics. 2018; 10(1):102.
PMID: 30075815
PMC: 6076404.
DOI: 10.1186/s13148-018-0536-6.
Bifunctional cross-linking approaches for mass spectrometry-based investigation of nucleic acids and protein-nucleic acid assemblies.
Scalabrin M, Dixit S, Makshood M, Krzemien C, Fabris D
Methods. 2018; 144:64-78.
PMID: 29753003
PMC: 7034459.
DOI: 10.1016/j.ymeth.2018.05.001.
Renal toxicity and chemotherapy in children with cancer.
Ruggiero A, Ferrara P, Attina G, Rizzo D, Riccardi R
Br J Clin Pharmacol. 2017; 83(12):2605-2614.
PMID: 28758697
PMC: 5698594.
DOI: 10.1111/bcp.13388.
Biodistribution of cisplatin revealed by imaging mass cytometry identifies extensive collagen binding in tumor and normal tissues.
Chang Q, Ornatsky O, Siddiqui I, Straus R, Baranov V, Hedley D
Sci Rep. 2016; 6:36641.
PMID: 27812005
PMC: 5095658.
DOI: 10.1038/srep36641.
The Cardiac Markers and Oxidative Stress Parameters in Advanced Non-Small Cell Lung Cancer Patients Receiving Cisplatin-Based Chemotherapy.
Demkow U, Biatas-Chromiec B, Stelmaszczyk-Emmel A, Radzikowska E, Wiatr E, Radwan-Rohrenschef P
EJIFCC. 2016; 22(1):6-15.
PMID: 27683384
PMC: 4975326.
Fertility preservation option in young women with ovarian cancer.
Kim S, Lee J
Future Oncol. 2016; 12(14):1695-8.
PMID: 27193251
PMC: 5549777.
DOI: 10.2217/fon-2016-0181.
